New Mexico Drug Policy Project - NM Santa Fe, Santa Fe 87501

New Mexico Drug Policy Project entered the industry of Social Service and Welfare Organizations in 0 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 6241901, which describes it as a Social Service and Welfare Organizations. For further clarification, the SIC classifies this business under the code 8322 and described it as a Social Service and Welfare Organizations. The business provides service to the B2C market.

To acquire more information, please contact by calling (505) 983-3277 during business hours. You can also write to the business’ Single Location at 343 East Alameda St, Santa Fe, New Mexico NM 87501. You can also visit the company’s website at drugpolicy.org. View this business’ social media profiles on Twitter or on Facebbok .

Company: New Mexico Drug Policy Project
Place of Business: 343 East Alameda St, Santa Fe, NM 87501
Contact Number: (505) 983-3277
Website: drugpolicy.org
Type of Service: Social Service and Welfare Organizations
SIC Number: 8322
NAICS Number: 6241901
Locality: Single Location
Market Type: B2C (Business to Consumer)
Income/Year: Unknown
Laborers: 1 to 4
Share This Company:

New Mexico Drug Policy Project is a company operating from Santa Fe, New Mexico providing professional Social Service and Welfare Organizations and relevant B2C variables. It was founded in 0 and registered with the SIC code 8322 as Social Service and Welfare Organizations, and with the NAICS code 6241901 as Social Service and Welfare Organizations.

With a current employee count of 1 to 4, New Mexico Drug Policy Project has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative at (505) 983-3277 for related queries, or to locate its Single Location using the coordinates 35.68457,-105.93207.

The Single Location can also be found at the street address 343 East Alameda St in Santa Fe, New Mexico 87501 and can be engaged online through the company website at drugpolicy.org, the company Twitter , and Facebook page .